Vertex Pharmaceuticals Incorporated (VRTX) reported a robust financial performance in its Third Quarter 2024 Earnings Call, with revenue reaching $2.77...
Read moreSemler Scientific Inc. (NASDAQ:SMLR), a company specializing in medical technology and services, reported mixed third-quarter financial results for 2024, with...
Read moreIntegra LifeSciences Holdings Corporation (IART), a leading global medical technology company, reported a decline in third-quarter 2024 revenue and adjusted...
Read moreWynn Resorts (NASDAQ: WYNN) reported a moderate increase in revenue and profitability in its Third Quarter 2024 Earnings Call held...
Read moreThe RealReal (NASDAQ:REAL), a leader in online luxury consignment, presented its financial results for the third quarter of 2024, showcasing...
Read moreBy Lucy Raitano and Samuel Indyk LONDON (Reuters) – Europe’s third-quarter earnings have mostly topped markets’ low expectations and investors...
Read moreBy Helen Reid and Mimosa Spencer LONDON/PARIS (Reuters) – Burberry’s new CEO Joshua Schulman faces an uphill task to turn...
Read moreInvesting.com– Boeing Co (NYSE:BA) workers voted in favor of the planemaker’s latest contract offer on Monday evening, ending a long-running strike...
Read more(Reuters) – Here is a side-by-side comparison of the key elements of three Boeing (NYSE:BA) contract deals for U.S. West...
Read moreInvesting.com – Australia stocks were lower after the close on Tuesday, as losses in the Gold, Utilities and Financials sectors...
Read moreDisclaimer: WallStreetJedi.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.